Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Ruiqiao He, Pan Li, Jinfeng Wang, Bota Cui, Faming Zhang & Fangqing Zhao. (2022) The interplay of gut microbiota between donors and recipients determines the efficacy of fecal microbiota transplantation. Gut Microbes 14:1.
Read now
Read now
Krishna Rao, Kavitha Santhosh, Jill A. Mogle, Peter D. R. Higgins & Vincent B. Young. (2016) Elevated fecal calprotectin associates with adverse outcomes from Clostridium difficile infection in older adults. Infectious Diseases 48:9, pages 663-669.
Read now
Read now
Amee R. Manges, Theodore S. Steiner & Alissa J. Wright. (2016) Fecal microbiota transplantation for the intestinal decolonization of extensively antimicrobial-resistant opportunistic pathogens: a review. Infectious Diseases 48:8, pages 587-592.
Read now
Read now
Szabolcs Vigvári, Zsuzsanna Nemes, Áron Vincze, Jenő Solt, Dávid Sipos, Zsófia Feiszt, Beáta Kovács, Barbara Bartos & Zoltán Péterfi. (2015) Faecal microbiota transplantation in Clostridium difficile infections. Infectious Diseases 47:2, pages 114-116.
Read now
Read now
Harsh Mathur, Mary C Rea, Paul D Cotter, R Paul Ross & Colin Hill. (2014) The potential for emerging therapeutic options for Clostridium difficile infection. Gut Microbes 5:6, pages 696-710.
Read now
Read now
Articles from other publishers (41)
Thanush D & M.P. Venkatesh. (2023) Fecal microbiota transplantation: History, procedure and regulatory considerations. La Presse Médicale 52:4, pages 104204.
Crossref
Crossref
Pratyusha Gaonkar. 2022. Contemporary Topics in Patient Safety - Volume 1. Contemporary Topics in Patient Safety - Volume 1.
Frederik Cold, Camilla Kara Svensson, Andreas Munk Petersen, Lars Hestbjerg Hansen & Morten Helms. (2022) Long-Term Safety Following Faecal Microbiota Transplantation as a Treatment for Recurrent Clostridioides difficile Infection Compared with Patients Treated with a Fixed Bacterial Mixture: Results from a Retrospective Cohort Study. Cells 11:3, pages 435.
Crossref
Crossref
Fahimeh Sadat Gholam-Mostafaei, Abbas Yadegar, Hamid Asadzadeh Aghdaei, Shabnam Shahrokh, Nasser Ebrahimi Daryani & Mohammad Reza Zali. (2021) Fecal microbiota transplantation for recurrent Clostridioides difficile infection in patients with concurrent ulcerative colitis. Acta Microbiologica et Immunologica Hungarica.
Crossref
Crossref
Anne Abildtrup Rode, Mahtab Chehri, Laura Rindom Krogsgaard, Kristine Klysner Heno, Anna Tølbøll Svendsen, Iben Ribberholt, Morten Helms, Jørgen Engberg, Kristian Schønning, Michael Tvede, Christian Østergaard Andersen, Ulrich Stab Jensen, Andreas Munk Petersen & Peter Bytzer. (2021)
Randomised clinical trial: a 12‐strain bacterial mixture versus faecal microbiota transplantation versus vancomycin for recurrent
Clostridioides difficile
infections
. Alimentary Pharmacology & Therapeutics 53:9, pages 999-1009.
Crossref
Crossref
Josbert J. Keller, Rogier E. Ooijevaar, Christian L. Hvas, Elisabeth M. Terveer, Simone C. Lieberknecht, Christoph Högenauer, Perttu Arkkila, Harry Sokol, Oleksiy Gridnyev, Francis Mégraud, Patrizia K. Kump, Radislav Nakov, Simon D. Goldenberg, Reetta Satokari, Sergiy Tkatch, Maurizio Sanguinetti, Giovanni Cammarota, Andrey Dorofeev, Olena Gubska, Gianluca Ianiro, Eero Mattila, Ramesh P. Arasaradnam, Shiv K. Sarin, Ajit Sood, Lorenza Putignani, Laurent Alric, Simon M. D. Baunwall, Juozas Kupcinskas, Alexander Link, Abraham G. Goorhuis, Hein W. Verspaget, Cyriel Ponsioen, Georgina L. Hold, Herbert Tilg, Zain Kassam, Ed J. Kuijper, Antonio Gasbarrini, Chris J. J. Mulder, Horace R. T. Williams & Maria J. G. T. Vehreschild. (2021) A standardised model for stool banking for faecal microbiota transplantation: a consensus report from a multidisciplinary UEG working group. United European Gastroenterology Journal 9:2, pages 229-247.
Crossref
Crossref
Devvrat Yadav & Sahil Khanna. (2021)
Safety of fecal microbiota transplantation for
Clostridioides difficile
infection focusing on pathobionts and SARS-CoV-2
. Therapeutic Advances in Gastroenterology 14, pages 175628482110096.
Crossref
Crossref
Stefano Bibbò, Carlo Romano Settanni, Serena Porcari, Enrico Bocchino, Gianluca Ianiro, Giovanni Cammarota & Antonio Gasbarrini. (2020) Fecal Microbiota Transplantation: Screening and Selection to Choose the Optimal Donor. Journal of Clinical Medicine 9:6, pages 1757.
Crossref
Crossref
Pamela Afouda, Marie Hocquart, Thi-Phuong-Thao Pham, Edmond Kuete, Issa Isaac Ngom, Niokhor Dione, Camille Valles, Sara Bellali, Jean-Christophe Lagier, Grégory Dubourg & Didier Raoult. (2020) Alcohol pretreatment of stools effect on culturomics. Scientific Reports 10:1.
Crossref
Crossref
Siew C Ng, Michael A Kamm, Yun Kit Yeoh, Paul K S Chan, Tao Zuo, Whitney Tang, Ajit Sood, Akira Andoh, Naoki Ohmiya, Yongjian Zhou, Choon Jin Ooi, Varocha Mahachai, Chun-Ying Wu, Faming Zhang, Kentaro Sugano & Francis K L Chan. (2020) Scientific frontiers in faecal microbiota transplantation: joint document of Asia-Pacific Association of Gastroenterology (APAGE) and Asia-Pacific Society for Digestive Endoscopy (APSDE). Gut 69:1, pages 83-91.
Crossref
Crossref
. (2019) UEG Week 2019 Oral Presentations. United European Gastroenterology Journal 7:S8, pages 10-188.
Crossref
Crossref
Jiunn-Wei Wang, Chao-Hung Kuo, Fu-Chen Kuo, Yao-Kuang Wang, Wen-Hung Hsu, Fang-Jung Yu, Huang-Ming Hu, Ping-I. Hsu, Jaw-Yuan Wang & Deng-Chyang Wu. (2019) Fecal microbiota transplantation: Review and update. Journal of the Formosan Medical Association 118, pages S23-S31.
Crossref
Crossref
Brooke C. Wilson, Tommi Vatanen, Wayne S. Cutfield & Justin M. O'Sullivan. (2019) The Super-Donor Phenomenon in Fecal Microbiota Transplantation. Frontiers in Cellular and Infection Microbiology 9.
Crossref
Crossref
Raghavendra PaknikarJoel Pekow. (2018)
Fecal Microbiota Transplantation for the Management of
Clostridium difficile
Infection
. Surgical Infections 19:8, pages 785-791.
Crossref
Crossref
Benjamin H Mullish, Mohammed Nabil Quraishi, Jonathan P Segal, Victoria L McCune, Melissa Baxter, Gemma L Marsden, David J Moore, Alaric Colville, Neeraj Bhala, Tariq H Iqbal, Christopher Settle, Graziella Kontkowski, Ailsa L Hart, Peter M Hawkey, Simon D Goldenberg & Horace R T Williams. (2018)
The use of faecal microbiota transplant as treatment for recurrent or refractory
Clostridium difficile
infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines
. Gut 67:11, pages 1920-1941.
Crossref
Crossref
Benjamin H. Mullish, Mohammed Nabil Quraishi, Jonathan P. Segal, Victoria L. McCune, Melissa Baxter, Gemma L. Marsden, David Moore, Alaric Colville, Neeraj Bhala, Tariq H. Iqbal, Christopher Settle, Graziella Kontkowski, Ailsa L. Hart, Peter M. Hawkey, Horace RT Williams & Simon D. Goldenberg. (2018) The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines. Journal of Hospital Infection 100, pages S1-S31.
Crossref
Crossref
Bryan Tungland. 2018. Human Microbiota in Health and Disease. Human Microbiota in Health and Disease
381
419
.
M. N. Quraishi, M. Widlak, N. Bhala, D. Moore, M. Price, N. Sharma & T. H. Iqbal. (2017)
Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory
Clostridium difficile
infection
. Alimentary Pharmacology & Therapeutics 46:5, pages 479-493.
Crossref
Crossref
Luis Furuya-Kanamori, Suhail A.R. Doi, David L. Paterson, Stefan K. Helms, Laith Yakob, Samantha J. McKenzie, Kjetil Garborg, Frida Emanuelsson, Neil Stollman, Matthew P. Kronman, Justin Clark, Charlotte A. Huber, Thomas V. Riley & Archie C.A. Clements. (2017) Upper Versus Lower Gastrointestinal Delivery for Transplantation of Fecal Microbiota in Recurrent or Refractory Clostridium difficile Infection. Journal of Clinical Gastroenterology 51:2, pages 145-150.
Crossref
Crossref
Soyoung Kim, Yeowool Lee & Seok-Hyun Kim. (2017) Safety and effectiveness of fecal microbiota transplantation: a systematic review. Journal of the Korean Medical Association 60:9, pages 761.
Crossref
Crossref
Lauren E. Hudson, Sarah E. Anderson, Anita H. Corbett & Tracey J. Lamb. (2017) Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies. Clinical Microbiology Reviews 30:1, pages 191-231.
Crossref
Crossref
J. König, A. Siebenhaar, C. Högenauer, P. Arkkila, M. Nieuwdorp, T. Norén, C. Y. Ponsioen, U. Rosien, N. G. Rossen, R. Satokari, A. Stallmach, W. de Vos, J. Keller & R. J. Brummer. (2016) Consensus report: faecal microbiota transfer – clinical applications and procedures. Alimentary Pharmacology & Therapeutics 45:2, pages 222-239.
Crossref
Crossref
Zeina Z. Berro, Righab H. Hamdan, Israa H. Dandache, Mohamad N. Saab, Hussein H. Karnib & Mahmoud H. Younes. (2016) Fecal microbiota transplantation for severe clostridium difficile infection after left ventricular assist device implantation: a case control study and concise review on the local and regional therapies. BMC Infectious Diseases 16:1.
Crossref
Crossref
Brandon C. Chapman, Hunter B. Moore, Douglas M. Overbey, Alex P. Morton, Ben Harnke, Mark E. Gerich & Jon D. Vogel. (2016) Fecal microbiota transplant in patients with Clostridium difficile infection. Journal of Trauma and Acute Care Surgery 81:4, pages 756-764.
Crossref
Crossref
Jennifer K. Spinler, Caná L. Ross & Tor C. Savidge. (2016) Probiotics as adjunctive therapy for preventing Clostridium difficile infection – What are we waiting for?. Anaerobe 41, pages 51-57.
Crossref
Crossref
Mohit Girotra, Shashank Garg, Rohit Anand, Yang Song & Sudhir K. Dutta. (2016) Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection in the Elderly: Long-Term Outcomes and Microbiota Changes. Digestive Diseases and Sciences 61:10, pages 3007-3015.
Crossref
Crossref
Cian Hill, R. Paul Ross, Catherine Stanton & Paul W. O'Toole. 2016. Host – Pathogen Interaction. Host – Pathogen Interaction
57
76
.
Y.-T. Li, H.-F. Cai, Z.-H. Wang, J. Xu & J.-Y. Fang. (2016)
Systematic review with meta-analysis: long-term outcomes of faecal microbiota transplantation for
Clostridium difficile
infection
. Alimentary Pharmacology & Therapeutics 43:4, pages 445-457.
Crossref
Crossref
M. Baxter & A. Colville. (2016) Adverse events in faecal microbiota transplant: a review of the literature. Journal of Hospital Infection 92:2, pages 117-127.
Crossref
Crossref
Sungmi ChoiSang-Heon ChoHana Yi. (2016) Human microbiome studies in Korea. Allergy, Asthma & Respiratory Disease 4:5, pages 311.
Crossref
Crossref
M. Nedim Ince, Bruce R. Blazar, Michael B. Edmond, Guido Tricot & Michael J. Wannemuehler. (2016) Understanding Luminal Microorganisms and Their Potential Effectiveness in Treating Intestinal Inflammation. Inflammatory Bowel Diseases 22:1, pages 194-201.
Crossref
Crossref
Krishna Rao & Nasia Safdar. (2015)
Fecal microbiota transplantation for the treatment of
Clostridium difficile
infection
. Journal of Hospital Medicine 11:1, pages 56-61.
Crossref
Crossref
Kelsey Shields, Roger V. Araujo-Castillo, Thimmaiah G. Theethira, Carolyn D. Alonso & Ciaran P. Kelly. (2015) Recurrent Clostridium difficile infection: From colonization to cure. Anaerobe 34, pages 59-73.
Crossref
Crossref
Colleen R. Kelly, Stacy Kahn, Purna Kashyap, Loren Laine, David Rubin, Ashish Atreja, Thomas Moore & Gary Wu. (2015) Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook. Gastroenterology 149:1, pages 223-237.
Crossref
Crossref
Dimitri DrekonjaJon ReichSelome GezahegnNancy GreerAasma ShaukatRoderick MacDonaldIndy RutksTimothy J. Wilt. (2015)
Fecal Microbiota Transplantation for
Clostridium difficile
Infection
. Annals of Internal Medicine 162:9, pages 630-638.
Crossref
Crossref
Silvia CaballeroEric G. Pamer. (2015) Microbiota-Mediated Inflammation and Antimicrobial Defense in the Intestine. Annual Review of Immunology 33:1, pages 227-256.
Crossref
Crossref
Krishna Rao & Vincent B. Young. (2015) Fecal Microbiota Transplantation for the Management of Clostridium difficile Infection. Infectious Disease Clinics of North America 29:1, pages 109-122.
Crossref
Crossref
U. Rosien, S. Hagel & M. Götz. (2015) Struhltransfer bei rezidivierenden Infektionen mit Clostridium difficileStool transplant for recurrent Clostridium difficile infection. Der Gastroenterologe 10:2, pages 122-126.
Crossref
Crossref
Lisa Blackburn, Andrea Bales, Mary Caldwell, Lee Cordell, Susan Hamilton & Haley Kreider. (2015) Fecal Microbiota Transplantation in Patients With Cancer Undergoing Treatment. Clinical Journal of Oncology Nursing 19:1, pages 111-114.
Crossref
Crossref
R. Satokari, E. Mattila, V. Kainulainen & P. E. T. Arkkila. (2015)
Simple faecal preparation and efficacy of frozen inoculum in faecal microbiota transplantation for recurrent
Clostridium difficile
infection - an observational cohort study
. Alimentary Pharmacology & Therapeutics 41:1, pages 46-53.
Crossref
Crossref
Ying Taur & Eric G Pamer. (2014) Harnessing Microbiota to Kill a Pathogen: Fixing the microbiota to treat Clostridium difficile infections. Nature Medicine 20:3, pages 246-247.
Crossref
Crossref